INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 443m ago
HOUSE PTR43m ago
SEC 13F43m ago
ROBINHOOD CHAIN42m ago
Corporate insider
DS

Duty Stuart

DirectorCIK 0001970274

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score12
Connections3with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
DS
Duty StuartDirector
FHTXFoghorn Therapeutics Inc.
Grant or award
A$114K
28.0K sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Foghorn Therapeutics Inc.Director · Jun 25, 2026
  • Insider ofevidence
    Milestone Pharmaceuticals Inc.Director · Jun 12, 2026
  • Insider ofevidence
    EyePoint, Inc.Director · Jan 6, 2026
9
DS
Duty StuartDirector
MISTMilestone Pharmaceuticals Inc.
Grant or award
A
—
77.0K sh
Jun 10, 2026
Jun 12, 2026
traded Jun 10, 2026
+2d
SEC FORM 4

Evidence

9
DS
Duty StuartDirector
EYPTEyePoint, Inc.
Grant or award
A—
40.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC FORM 4

Evidence